STAT3 and neoplasm: Attribution of changes in NK cell effector functions to the activation of the STAT3 pathway is supported by the observation that genetic ablation of STAT3 in hematopoietic cells of mice bearing B16 melanoma resulted in greater cytotoxicity of spleen NK cells compared to those from tumor-bearing wild-type mice [6].